Clinical Trials Of New Stent Using Revolutionary Biomaterial

A revolutionary, new biomaterial, developed at the New Jersey Center for Biomaterials (NJCBM) at Rutgers University, has moved from the lab bench to field testing in record time. This achievement, a product of a breakthrough methodology in biomaterials discovery, is the enabling technology behind a coronary stent undergoing its first-in-human clinical trial in Germany and in Brazil.Stents are tiny tubes inserted into diseased arteries to keep them open. [click link for full article]

More: continued here

Filed under: Cardiovascular on October 20th, 2007